Teladoc Health（纽约证券交易所代码：TDOC）报告季度每股亏损为 $0.28，低于分析师共识预期的 $0.23，低 21.74%。相比去年同期每股亏损 $0.17，减少了 64.71%。该公司报告季度销售额为 $640.500 百万美元，高于分析师共识预期的 $639.552 百万美元，高 0.15%。相比去年同期销售额 $660.527 百万美元，减少了 3.03%。

以上内容来自Benzinga Earnings专栏，原文如下：

Teladoc Health (NYSE:TDOC) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.23) by 21.74 percent. This is a 64.71 percent decrease over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $640.500 million which beat the analyst consensus estimate of $639.552 million by 0.15 percent. This is a 3.03 percent decrease over sales of $660.527 million the same period last year.